MXCT Earnings Prediction
The chart below shows how MXCT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MXCT sees a +5.18% change in stock price 10 days leading up to the earnings, and a +5.09% change 10 days following the report. On the earnings day itself, the stock moves by -2.11%. This data can give you a slight idea of what to expect for the next quarter's release.
MXCT Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
8.16M
1.99%
-21.72%
Gross Margin
63.88%
-17.24%
-15.75%
Operating Margin
-172.13%
-1.25%
49.99%
Net Margin
-141.56%
0.70%
57.48%
EPS
-0.11
-0.00%
22.22%
No Data Available
MXCT Earnings Analysis
MaxCyte, Inc. Common Stock Corporation (MXCT.O) Earnings Conference Call
Positive
Quarterly Revenue Increase: MaxCyte reported $8.2 million of total revenue in the third quarter, representing a 2% increase compared to $8 million in the third quarter of 2023.
Core Revenue Increase: Core revenue was reported at $8.1 million compared to $6.6 million in the comparable prior year quarter, representing a 23% increase.
Instrument Revenue Growth: Instrument revenue was $1.8 million compared to $1.7 million in the third quarter of 2023, indicating growth.
Leaser Revenue Stability: Leaser revenue was $2.5 million compared to $2.4 million in the third quarter of 2023, showing stability.
PA Revenue Growth: Processing assembly or PA revenue was $3.4 million compared to $2.2 million in the comparable prior year quarter, demonstrating strong growth.
Negative
Quarterly Revenue Increase: Total revenue in the third quarter of 2024 was $8.2 million compared to $8 million in the third quarter of 2023, representing an increase of 2%.
Core Revenue Increase: Core revenue of $8.1 million compared to $6.6 million in the comparable prior year quarter representing an increase of 23%.
Instrument Revenue Increase: Instrument revenue was $1.8 million compared to $1.7 million in the third quarter of 2023.
Leaser Revenue Increase: Leaser revenue was $2.5 million compared to $2.4 million in the third quarter of 2023.
PA Revenue Increase: Processing assembly or PA revenue was $3.4 million compared to $2.2 million in the comparable prior year quarter.
MXCT FAQs
How does MXCT typically perform around its earnings report dates?
Is MaxCyte, Inc. (MXCT) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
MXCT Earning Call Sentiment
MaxCyte, Inc. (MXCT) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
MXCT.O
-3.98%Positive
The earnings call presents mixed signals. Financial performance shows some growth, with core revenue up and a strong cash position, but gross margins have declined significantly. The Q&A reveals cautious optimism but lacks clarity on future improvements and growth rates. The increase in core revenue expectations is positive, but the immaterial SPL revenue and lack of additional milestone payments are concerning. Overall, the sentiment is neutral, balancing positive core revenue growth against declining margins and unclear future guidance.
